Cargando…
Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet
Hypertension is frequently comorbid with the disorders of glucose and lipid metabolism. The increased intakes of fructose and salt contribute to the development of hypertension and related metabolic disorders, which are closely associated with gut dysbiosis. Fufang-Zhenzhu-Tiaozhi capsule (FTZ), a t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277139/ https://www.ncbi.nlm.nih.gov/pubmed/35846749 http://dx.doi.org/10.3389/fcimb.2022.854849 |
_version_ | 1784745886405885952 |
---|---|
author | Chen, Zhe Yang, Bin Wang, Zhen Rong, Xianglu Zhu, Qing Guo, Jiao |
author_facet | Chen, Zhe Yang, Bin Wang, Zhen Rong, Xianglu Zhu, Qing Guo, Jiao |
author_sort | Chen, Zhe |
collection | PubMed |
description | Hypertension is frequently comorbid with the disorders of glucose and lipid metabolism. The increased intakes of fructose and salt contribute to the development of hypertension and related metabolic disorders, which are closely associated with gut dysbiosis. Fufang-Zhenzhu-Tiaozhi capsule (FTZ), a traditional Chinese patent medicine commonly used in clinical practice, has recently emerged as a promising drug candidate for metabolic diseases. In this study, FTZ treatment is identified as attenuating blood pressure increase and improving the metabolism of lipid and uric acid in high-fructose and high-salt (HFS) diet-fed rats. FTZ also substantially alleviated renal fibrosis and the mRNA expression of inflammation cytokines, NADPH oxidases, and the renin–angiotensin system in the renal cortex. 16S rRNA sequencing of fecal samples revealed that FTZ restored HFS-induced gut dysbiosis, seen as increased intestinal microbial richness and diversity. Furthermore, fecal microbiota transplantation also achieved similar therapeutic effects and alterations in gut microbiota profile induced by FTZ. Taken together, this study highlights the efficacy of FTZ in attenuating HFS-induced hypertension and related metabolic disorders and renal injury. The antihypertensive effect is associated with the modulation of gut microbiota. |
format | Online Article Text |
id | pubmed-9277139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92771392022-07-14 Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet Chen, Zhe Yang, Bin Wang, Zhen Rong, Xianglu Zhu, Qing Guo, Jiao Front Cell Infect Microbiol Cellular and Infection Microbiology Hypertension is frequently comorbid with the disorders of glucose and lipid metabolism. The increased intakes of fructose and salt contribute to the development of hypertension and related metabolic disorders, which are closely associated with gut dysbiosis. Fufang-Zhenzhu-Tiaozhi capsule (FTZ), a traditional Chinese patent medicine commonly used in clinical practice, has recently emerged as a promising drug candidate for metabolic diseases. In this study, FTZ treatment is identified as attenuating blood pressure increase and improving the metabolism of lipid and uric acid in high-fructose and high-salt (HFS) diet-fed rats. FTZ also substantially alleviated renal fibrosis and the mRNA expression of inflammation cytokines, NADPH oxidases, and the renin–angiotensin system in the renal cortex. 16S rRNA sequencing of fecal samples revealed that FTZ restored HFS-induced gut dysbiosis, seen as increased intestinal microbial richness and diversity. Furthermore, fecal microbiota transplantation also achieved similar therapeutic effects and alterations in gut microbiota profile induced by FTZ. Taken together, this study highlights the efficacy of FTZ in attenuating HFS-induced hypertension and related metabolic disorders and renal injury. The antihypertensive effect is associated with the modulation of gut microbiota. Frontiers Media S.A. 2022-06-29 /pmc/articles/PMC9277139/ /pubmed/35846749 http://dx.doi.org/10.3389/fcimb.2022.854849 Text en Copyright © 2022 Chen, Yang, Wang, Rong, Zhu and Guo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Chen, Zhe Yang, Bin Wang, Zhen Rong, Xianglu Zhu, Qing Guo, Jiao Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet |
title | Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet |
title_full | Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet |
title_fullStr | Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet |
title_full_unstemmed | Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet |
title_short | Modulation of the Gut Microbiota by Fufang-Zhenzhu-Tiaozhi Capsule Attenuates Hypertension Induced by a High-Fructose and High-Salt Diet |
title_sort | modulation of the gut microbiota by fufang-zhenzhu-tiaozhi capsule attenuates hypertension induced by a high-fructose and high-salt diet |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277139/ https://www.ncbi.nlm.nih.gov/pubmed/35846749 http://dx.doi.org/10.3389/fcimb.2022.854849 |
work_keys_str_mv | AT chenzhe modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet AT yangbin modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet AT wangzhen modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet AT rongxianglu modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet AT zhuqing modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet AT guojiao modulationofthegutmicrobiotabyfufangzhenzhutiaozhicapsuleattenuateshypertensioninducedbyahighfructoseandhighsaltdiet |